Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research Receives $5 Million Grant From The Bob & Renee Parsons Foundation
Mount Sinai Health SystemFunds will support cutting-edge MDMA-assisted therapy for PTSD
Funds will support cutting-edge MDMA-assisted therapy for PTSD
New York Medical Partners ACO, LLC (NYMP), met quality and cost goals for the management of about 50,000 Medicare beneficiaries in the Medicare Shared Savings Program, resulting in more than $28 million in savings to Medicare, according to recently released performance data from the Centers for Medicare & Medicaid Services (CMS).
New features include upload for COVID-19 vaccination proof and hospital navigation
Researchers at the Icahn School of Medicine at Mount Sinai found that a tool commonly used in research for evaluating a person’s genetic risk for a disease, called a polygenic risk score, was no better at predicting the outcome of a schizophrenia patient’s disease over time than written reports. The results raise important questions about the use of polygenic risk scores in real-world, clinical situations, and also suggest that a doctor’s written report may be an untapped source of predictive information.
Scientists at the Icahn School of Medicine at Mount Sinai described the creation of a new, automated, artificial intelligence-based algorithm that can learn to read patient data from electronic health records. In a side-by-side comparison, they showed that their method, called Phe2vec (FEE-to-vek), accurately identified patients with certain diseases as well as the traditional, “gold-standard” method, which requires much more manual labor to develop and perform
New scientific statement aims to establish more streamlined care to improve outcomes in this high-risk group
In an effort to understand how these states influence the brain’s decision-making processes, scientists at the Icahn School of Medicine at Mount Sinai analyzed the data from a previous pre-clinical study. They found that two of the brain’s decision-making centers contain neurons that may exclusively monitor the body’s internal dynamics. Furthermore, a heightened state of arousal appeared to rewire one of the centers by turning some decision-making neurons into internal state monitors.
For the ninth consecutive year, Mount Sinai will serve as the official medical services provider for the 2021 US Open Tennis Championships, which begin on Monday, August 30, and run through Sunday, September 12.
Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial
Department of Rehabilitation and Human Performance will lead Mount Sinai in national clinical trial
In a study of rodents, scientists at the Icahn School of Medicine at Mount Sinai discovered that a part of the brain traditionally thought to control typing the old habits may also play a critical role in learning the new actions. The results, published on August 25th in Nature Communications, suggest that this process involves a delicate balance in the activity of two neighboring neural circuits: one dedicated to new actions and the other to old habits
The hospital achieved this recognition by meeting rigorous standards for performing endovascular thrombectomy and demonstrating continuous compliance with its performance standards.
Hospital quality of care during delivery is a major factor for racial and ethnic disparities among low-risk newborns
In a study to be published this coming Monday, August 23, at 11 am Eastern (please note embargo) in JAMA Internal Medicine, Mount Sinai researchers discuss a troubling rise in homebound older adults that underlines the inequality of the pandemic.
The Mount Sinai Health System announced today a game-changing $60 million gift from James S. and Merryl H. Tisch to establish the Mount Sinai Tisch Cancer Center.
The absence of a protein that activates the body’s antiviral defenses can cause a rare rheumatoid-like autoinflammatory condition that is treatable with an FDA-approved class of drugs known as TNF (tumor necrosis factor) inhibitors, a global research team led by Mount Sinai has found.
Awards highlight highest level of quality of care
Mount Sinai’s Interim Executive Director and Chief Operating Officer, Cameron R. Hernandez, MD, has been appointed Executive Director and Chief Operating Officer at Mount Sinai Queens.
Unique technology enhances outcomes during life-threatening emergencies
The use of artificial intelligence and machine learning enable new insights to help diagnose illness, suggest specific courses of treatment and follow patient’s progress
Mount Sinai Health System today announced that all faculty and staff will be required to get the first shot of the vaccine by September 13.
Mount Sinai researchers have found an important clue to a rare but serious aftereffect of COVID-19 in children, known as multisystem inflammatory syndrome in children or MIS-C.
The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus (HPV) infection.
Expanding upon its nearly 170-year history of innovation and discovery, the Mount Sinai Health System has launched a bold capital campaign to raise $2 billion by 2025 that will power the organization into a forward-looking era of advanced patient care, research, and education.
Study finds stroke patients are nearly twice as likely to be functionally independent if treated by a specialized team that travels to them to perform surgical clot removal
The Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) and Meharry Medical College in Nashville, Tennessee, today announced they have entered into an agreement that will address racism and bias in the basic sciences and introduce greater diversity and inclusion.
Mount Sinai researchers have found evidence for the first time that World Trade Center responders had a higher likelihood of developing liver disease if they arrived at the site right after the attacks as opposed to working at Ground Zero later in the rescue and recovery efforts. Their study links the increase in liver disease risk to the quantity of toxic dust the workers were exposed to, which was greatest immediately after the September 11, 2001, attacks.
With generous support from the Josiah Macy Jr. Foundation, the Icahn School of Medicine at Mount Sinai announced today a three-year project to replicate its model for dismantling systemic racism in medical education. The school has put forth a Request for Proposal (RFP) seeking eight to ten partner medical schools in the United States and Canada who will participate in the Icahn Mount Sinai learning model, centered on a virtual learning platform.
Researchers at the Seaver Autism Center for Research and Treatment at Mount Sinai have identified specific transient visual evoked potential waveform abnormalities in individuals with Phelan-McDermid syndrome (PMS), proving the method to be an effective, noninvasive technique to gather objective data from a range of individuals, including those who are profoundly affected.
J Mocco, MD, MS, Senior Vice Chair, Director of the Cerebrovascular Center, and Co-Director of the Neuroendovascular Surgery Fellowship Program in the Department of Neurosurgery at Mount Sinai, has been named president-elect of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery, effective July 29, 2021.
The Phillips School of Nursing at Mount Sinai Beth Israel (PSON) has been awarded more than $1.8 million over four years from the Health Resources & Services Administration (HRSA) to build on the school’s efforts in recruiting a diverse group of students and further creating an equitable environment. The grant is made possible through the Nursing Workforce Diversity Program, which helps to recruit, support, retain, and graduate nursing students from disadvantaged backgrounds including racial and ethnic minorities underrepresented in nursing.
The Mount Sinai Hospital’s Department of Geriatrics was ranked No. 1 in the nation by U.S. News & World Report for the second consecutive year. The Mount Sinai Hospital was also listed on the “Honor Roll” of the nation’s top 20 hospitals for the sixth year in a row.
Frontotemporal dementias are a group of fatal and debilitating brain disorders for which there are no cures. In an article published July 26 in Cell, Mount Sinai researchers describe how they were able to recreate much of the damage seen in a widely studied form of the disease by growing special types of cerebral organoids in petri dishes.
The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai today announced a $2.1 million charitable contribution by the Steven & Alexandra Cohen Foundation.
Kalmon D. Post, MD, Surgical Co-Director of the Pituitary Care and Research Center, and Chair Emeritus of the Department of Neurosurgery, the Faculty Practice Associates, and The Medical Board at Mount Sinai, has been named president-elect of The Pituitary Society, effective Thursday, July 1
Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.
Mount Sinai researchers uncover a potential pathway for treatment that can prevent blindness
Filip Swirski, PhD, named Director of Mount Sinai’s new Cardiovascular Research Institute
Department of Rehabilitation and Human Performance prepares athletes for Tokyo Olympic Games
Mount Sinai researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention. In a study published in mBio, the team reported how a protein of the Ebola virus, VP24, interacts with the double-layered membrane of the cell nucleus (known as the nuclear envelope), leading to significant damage to cells along with virus replication and the propagation of disease.
Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Education and Director of the Precision Prostatectomy Program in the Department of Urology at Icahn Mount Sinai and Center of Excellence for Prostate Cancer at The Tisch Cancer Institute.
Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado. Presented by the Aspen Institute and sponsored by the Mount Sinai Health System, the festival is a unique forum for the exchange of ideas.
Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines—in some cases, no detectable response—pointing to the need for antibody testing and precautions for these patients after vaccination, according to a study published in Cancer Cell in June.
Repetitive overhead throwing is a risk factor for shoulder injuries in collegiate baseball players, often leading to rotator cuff and biceps tendon injuries.
Only center in the world with this combination of distinctions
A new class of drugs that inhibits a “master switch” involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin’s lymphoma, has been discovered by researchers at Mount Sinai.
Cardiologist will partner with organization to create awareness for congenital heart disease to improve community health